Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Regranex Gel (becaplermin 0.01%) - Important Safety Information from Janssen-Cilag Ltd as approved by the Irish Medicines Board

20 June 2011

Important Safety Information communication from Janssen-Cilag Ltd on the cessation of supply of Regranex Gel (becaplermin 0.01%) in Europe.

Important Safety Information - Regranex Gel

Date Printed: 19 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971